Sfoglia per AUTORE
MINA R
Collezione AOU Novara

  

Items : 15

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2024 Jan 1;109(1):245-255. doi: 10.3324/haematol.2023.283251.

2024
AOU Città della Salute di Torino
AOU Novara

Morabito F; Neri A; Di Raimondo F; Petrucci MT; Nappi D; Bertuglia G; Ferretti E; Sgherza N; Rizzi R; Cotzia E; Gozzetti A; Bongarzoni V; Rossini B; Fontana R; Accardi F; Amico V; Amendola A; Vincelli D; Brunori M; Palumbo G; Pompa A; Uccello G; Barilà G; Casaluci GM; Rago A; Ria R; Tarantini G; Offidani M; Cerchione C; et alii...

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
ASL Torino 5
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara

Corradini P; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Visco C; Bertù L; Pagano L; Guidetti A; Coviello E; Passamonti F; Bocchia M; Gentile M; Della Porta MG; Mohamed S; Mauro FR; Gambacorti-Passerini C; Massaia M; Billio A; Scattolin A; Marchesi F; Fracchiolla NS; Cattaneo C; Derenzini E; Arcaini L; Trentin L; et alii...

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AO Alessandria

Bertù L; Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Visco C; Romano A; Coviello E; Merli F; Passamonti F; Krampera M; Corradini P; Candoni A; Conconi A; Tosi P; Lanza F; Venditti A; Selleri C; Vallisa D; Visani G; Gambacorti-Passerini C; La Barbera EO; Rigacci L; Armiento D; Cilloni D; Corso A; Cardinali V; et alii...

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Pagano L; Corradini P; Bertù L; Petrucci L; Zaja F; Grossi PA; Musto P; Visani G; Lanza F; Cattaneo C; La Barbera EO; Mina R; Cardinali V; Galimberti S; Luppi M; Krampera M; Fracchiolla N; Bocchia M; Candoni A; Armiento D; Arcaini L; Tafuri A; Busca A; Marchesi F; Pinto A; Massaia M; Ladetto M; Venditti A; Cairoli R; et alii...

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Jul 1;27(13):3695-3703. doi: 10.1158/1078-0432.CCR-21-0134. Epub 2021 Apr 29.

2021
AOU Città della Salute di Torino
AOU Novara

Gay F; Boccadoro M; Spencer A; Sonneveld P; Musto P; Hájek R; Gaidano G; Nagler A; Benevolo G; Belotti A; Patriarca F; Mina R; Cascavilla N; Ruggeri M; de Fabritiis P; Liberati AM; Mannina D; Capra A; Romano A; Corradini P; Offidani M; Petrucci MT; Zaccaria GM; Bertamini L;

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. in Annals of hematology / Ann Hematol. 2021 Feb;100(2):437-443. doi: 10.1007/s00277-020-04384-w. Epub 2021 Jan 3.

2021
AOU Città della Salute di Torino
AOU Novara

Omedé P; Boccadoro M; Bringhen S; Genuardi E; Saraci E; Margiotta Casaluci G; Mina R; Gilestro M; D'Agostino M; Oddolo D; Troia R; Caltagirone S; Oliva S; De Paoli L; Ruggeri M;

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Cea M; Offidani M; Boccadoro M; Larocca A; Monaco F; Corradini P; Belotti A; Paris L; Grasso M; Aquino S; De Paoli L; Rota-Scalabrini D; Bonello F; Ballanti S; De Sabbata G; Zambello R; Tacchetti P; Cellini C; Patriarca F; Musolino C; Ciccone G; Capra A; Pescosta N; Petrucci MT; Bringhen S; Liberati AM; Mina R; Falcone AP;

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies. in Haematologica / Haematologica. 2021 Apr 1;106(4):1079-1085. doi: 10.3324/haematol.2019.243428.

2021
AOU Città della Salute di Torino
AOU Novara

Bringhen S; Boccadoro M; Omedé P; Gaidano G; Palumbo A; Montefusco V; Cavo M; Siniscalchi A; Gilestro M; Galieni P; Capra A; Benevolo G; Olivieri A; Musto P; Ballanti S; Liberati AM; Conticello C; Petrucci MT; Bonello F; Mina R;

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents. in Blood cancer journal / Blood Cancer J. 2020 Apr 14;10(4):40. doi: 10.1038/s41408-020-0307-4.

2020
AOU Città della Salute di Torino
AOU Novara

Terpos E; Lonial S; De Paoli L; Jaye DL; Belotti A; Offidani M; Oliva S; Giuliani N; Roussou M; Omedé P; Boise LH; Patriarca F; Gavriatopoulou M; Montefusco V; Kaufman JL; Petrucci MT; Kastritis E; Gay F; Joseph NS; Mina R; Boccadoro M; Nooka AK; Dimopoulos MA;

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. in Haematologica / Haematologica. 2020 Apr;105(4):1074-1080. doi: 10.3324/haematol.2019.220657. Epub 2019 Jun 27.

2020
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Hájek R; Boccadoro M; Bringhen S; Palumbo A; De Paoli L; Romano A; Falcone AP; Zambello R; Giuliani N; Fraticelli V; Paris L; Amico V; Musto P; Innao V; Cangiolosi C; Bernardini A; Oddolo D; Benevolo G; Spada S; Patriarca F; Evangelista A; Liberati AM; Ledda A; Offidani M; Mina R; Larocca A;

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. in Haematologica / Haematologica. 2019 Aug;104(8):1640-1647. doi: 10.3324/haematol.2018.208272. Epub 2019 Feb 7.

2019
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Di Raimondo F; Montefusco V; Di Toritto TC; Cavo M; Galieni P; Ponticelli E; Benevolo G; Spada S; Offidani M; Musto P; Ballanti S; Gaidano G; Petrucci MT; Mina R; Bringhen S; Boccadoro M; Larocca A;

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19

2018
AOU Città della Salute di Torino
AOU Novara

Corradini P; Tacchetti P; Musto P; Nagler A; Ria R; Caravita T; Benevolo G; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Rizzi R; Cascavilla N; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Patriarca F; Crippa C; Spada S; De Paoli L; Di Raimondo F; Cerrato C; Offidani M; Palumbo A; Petrucci MT; et alii...

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):533-540. doi: 10.1016/j.clml.2018.05.019. Epub 2018 May 2

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Hájek R; Calafiore V; Nagler A; Palumbo A; Falcone AP; Zambello R; Benevolo G; Mannina D; Guglielmelli T; Gamberi B; Baldini L; Musto P; Malfitano A; Ria R; Pescosta N; De Paoli L; Cerrato C; Patriarca F; Spada S; Corradini P; Mina R; Petrucci MT; Spencer A; Boccadoro M; Bringhen S;

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.

2018
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M;

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. in Blood / Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Guglielmelli T; Ledda A; Zambello R; Ruggeri M; Maisnar V; Ciccone G; Conticello C; Pulini S; Bernardini A; Musolino C; Giuliani N; Gentili S; Pietrantuono G; De Paoli L; Falcone AP; Mina R; Patriarca F; Benevolo G; Offidani M; Bringhen S; Magarotto V; Montefusco V; Hajek R; Boccadoro M; Palumbo A;